Amanda Blackford, Sc.M. |
Research
Bioinformatics
Amanda currently collaborates with
Dr. Jeanne Kowalski
on development of nonparametric methods for analysis of bioinformatic data, ranging from microarrays, SNPs and karyotyping data. The
areas of application for these methods is varied, from immunology and pathology to specific types of cancers, such as lung, prostate and pancreas.
Amanda also works with
Dr. Giovanni Parmigiani and serves at the organizer and contact person for the
BayesMendel group, which is dedicated to the development of methodologies, models, and open source
software for predicting who may carry a cancer susceptibility gene. Software is currently available for breast and colorectal cancers.
Clinical Trials
Amanda also collaborates with oncologists and other investigators in the SKCCC on the design,
protocol development and analysis of clinical trials. She is currently collaborating with
Dr. Elizabeth Garrett-Mayer on developing methods for early stopping in Phase II trials when
the outcome of interest is a time to event.
She is also involved in two projects within the Bloomberg School of Public Health's Center
for Clinical Trials, the National Emphysema Treatment Trial (NETT) and the
Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT). NETT is a multi-center randomized clinical trial
comparing lung volume reduction surgery to medical therapy alone. Visit the Center's
website for more information about NETT.
Other Research
Amanda also continues her work with the School of Public Health's Institute
for Global Tobacco Control and Dr.
Jon Samet. They are currently collaborating with investigators from Mexico,
Brazil, China and Poland on analyzing cotinine data from smokers in these
countries.